GlassScriptPhysician profile
Ronald J Mullis
NPI 1093729246
$35,837.93
in general payments reported to CMS, 2019-2025
27 companies · $38.30 in 2025
The $38.30 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,275 · 2021: $306 · 2022: $8,924 · 2023: $3,316 · 2024: $200 · 2025: $38.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,020 · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,020.00 |
| Food and Beverage | $534.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,222.86 | 2019-2023 | Davinci Xi |
| Csl Behring | $276.02 | 2021-2024 | Kcentra |
| Organogenesis INC. | $265.07 | 2022-2025 | Puraply, Apligraf, Affinity |
| Davol INC. | $241.46 | 2020-2023 | Phasix Mesh |
| Ethicon US, LLC | $121.97 | 2019-2020 | |
| Angiodynamics, INC. | $71.50 | 2019-2021 | |
| Integra Lifesciences Corporation | $71.23 | 2019 | |
| Medtronic, INC. | $65.61 | 2021-2024 | Ligasure |
| Acell, INC. | $55.79 | 2019-2020 | |
| Polynovo North America LLC | $54.22 | 2022 | |
| Teleflex LLC | $47.99 | 2022-2023 | Quikclot |
| Kci USA, INC. | $42.45 | 2021 | |
| Smith+Nephew, INC. | $41.57 | 2022 | |
| Innocoll Pharmaceuticals Limited | $35.32 | 2021-2022 | |
| Ambu INC. | $30.97 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $20.49 | 2019 | |
| Acera Surgical, INC. | $19.79 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.38 | 2023 | Gattex |
| Pacira Pharmaceuticals Incorporated | $18.37 | 2019 | |
| Heron Therapeutics, INC. | $17.70 | 2021 | |
| Boston Scientific Corporation | $16.69 | 2019 | |
| Solventum Corporation | $16.27 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Covidien LP | $15.96 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.29 | 2025 | Voquezna |
| Getinge USA Sales, LLC | $12.99 | 2021 | |
| Osiris Therapeutics INC. | $12.66 | 2019 | |
| Kerecis Limited | $9.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Mullis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.